Skip to main content Skip to menu Skip to footer
Home
  • Contact Us
  • Join us
  • Make an appointment
  • Donors
    • Patients and relatives
    • Researchers
    • Students
    • Caregivers
    • Journalists
    • TechTransfer
Search
Directory of Doctors
  • FR
  • EN
Make a donation
  • Who we are
    • Our history
    • Our missions
    • Annual Report 2020 – Working together to beat cancer
    • Our economic model
    • Our missions
    • Our organization
  • Understand cancer
    • Breast cancer
    • Childhood cancers
    • Immunotherapy
    • Retinoblastoma
    • Sarcomas
    • Uveal melanoma
    • Proton therapy
    • Developing the Radiotherapy of the Future
    • Lung cancer
  • Support us
    • Get involved
    • Our supporters
    • Where does your donation go?
  • Strategic priorities
    • Breast cancer
    • Early trials
    • Genetics and epigenetics
    • Immunotherapy
    • Pediatric cancer
    • Radiotherapy and radiation biology
    • Sarcomas
    • Uveal melanoma
  • Annual report
  • Research News
Breadcrumb
  1. Institut Curie
  2. Donors
  3. News
Find out about our latest news.
épigénétique
Publication
How do our cells pass on their epigenetic markers?11/19/2021
manipulation
Publication
Immune system: spotlight on monocyte fate11/18/2021
Liban - DRI
Openness
Institut Curie’s expertise goes global11/05/2021
Judith Pineau
Award
Judith Pineau wins the L’Oréal-Unesco Young Talents France 2021 for Women in Science award10/14/2021
Couvertures RA
Corporate
Annual Report 2020 – Working together to beat cancer09/22/2021
Portrait Pr Steven Le Gouill - nouveau direction de l'ensemble hospitalier
Corporate
Prof. Steven Le Gouill, new Director of the Hospital Group at Institut Curie08/31/2021
Détection du tissu d'origine chez les patients atteints de cancers d’origine inconnue grâce à l’IA
Publication
Institut Curie is developing an artificial intelligence tool for diagnosing cancer of un-known primary08/16/2021
Centre de Recherche Institut Curie
Publication
FHL3: A Scaffold Protein, Architect of the Embryonic Nervous System07/30/2021
COMPASS
Pediatric cancers
Pediatric Cancer: Identifying New Therapies with the European COMPASS Project07/13/2021
Mondrian
Innovation
Institut Curie launches the first study to assess the clinical utility of circulating tumor DNA in the evaluation of chemotherapy response07/13/2021

Pagination

  • First page « First
  • Page précédente First page
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Page suivante Next Page
  • Last page Last Page
Sign up to our Newsletter
Join us
Follow us
  • facebook
  • twitter
  • linkedin
  • instagram
Patients and relatives
  • Our hospitals
  • Adult care
  • International patients
  • What is a clinical trial?
  • Care News
Access this area
Donors
  • Who we are
  • Understand cancer
  • Support us
  • Strategic priorities
  • Annual report
  • Research News
Access this area
Researchers
  • Research Center
  • Thematic areas of research
  • Research Units
  • Research Teams
  • Core Facilities
  • Seminars
  • Programs and partnerships
  • Training
  • Join us
  • Research News
Access this area
Students
  • Courses
  • The hospital
  • The Research Center
  • Collaborations
  • ADIC
  • Training News
Access this area
Caregivers
  • Refer a patient
  • Understanding cancer
  • Our expertise
  • Our hospitals
  • Contact Us
  • Care News
Access this area
Journalists
  • Press Release
  • Understanding cancer
Access this area
TechTransfer
  • About us
Access this area
  • Copyright © 2022
  • Contact and Access
  • Contact Us
  • Directory
  • Join us
  • Legal Notice
  • Personal data protection charter